Company News
-
Company News
Announces 2026 Interim Results26 August,2026
Learn More
-
Company News
Announces 2025 Annual Results，Record-Breaking Revenue of HK$586.2M and EPS Surged to HK$1.56 Cents27 March,2026
Learn More
-
Company News
Uni-Bio Science Group Joins Forces with Wenzhou Medical University National Engineering Research Center and Ouhai District Government to Build Growth Factor Innovation Ecosystem and Accelerate Regenerative Medicine Strategy Layout30 December,2025
Learn More
-
Company News
Uni-Bio Science Group Honored with SCMP "Company of the Year" Award16 December,2025
Learn More
-
Announces 2026 Interim Results
Company News
26 August,2026
-
Announces 2025 Annual Results，Record-Breaking Revenue of HK$586.2M and EPS Surged to HK$1.56 Cents
Company News
27 March,2026
-
Uni-Bio Science Group Joins Forces with Wenzhou Medical University National Engineering Research Center and Ouhai District Government to Build Growth Factor Innovation Ecosystem and Accelerate Regenerative Medicine Strategy Layout
Company News
30 December,2025
-
Uni-Bio Science Group Honored with SCMP "Company of the Year" Award
Company News
16 December,2025
-
Uni-Bio Science Group Embarks on New Strategy and Launches New Website, Advancing Towards Becoming a Global Leader in Regenerative MedicineCompany News
24 November,2025
-
Uni-Bio Science Group and Kexing Biopharm Forge Strategic Partnership to Accelerate Global Expansion of Osteoporosis Treatment Bogutai®Company News
12 September,2025
-
Announces 2025 Interim ResultsCompany News
29 August,2025
-
Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in ChangshaCompany News
02 July,2025
-
Uni-Bio Science Group Receives NMPA Approval for 金因康® (Diquafosol Sodium Eye Drops), Advancing Dry Eye Syndrome Treatment in ChinaCompany News
22 May,2025
